Primary sclerosing cholangitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Primary sclerosing cholangitis}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Primary_sclerosing_cholangitis]]
{{CMG}}; {{AE}}{{DN}}
{{CMG}}; {{AE}}{{DN}}{{Akshun}}


==Overview==
==Overview==
Line 9: Line 9:


Primary sclerosing cholangitis must be differentiated from causes of secondary sclerosing cholangitis. These include:<ref name="pmid27653566">{{cite journal |vauthors=Lazaridis KN, LaRusso NF |title=Primary Sclerosing Cholangitis |journal=N. Engl. J. Med. |volume=375 |issue=12 |pages=1161–70 |year=2016 |pmid=27653566 |doi=10.1056/NEJMra1506330 |url=}}</ref><ref name="pmid20101749">{{cite journal |vauthors=Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ |title=Diagnosis and management of primary sclerosing cholangitis |journal=Hepatology |volume=51 |issue=2 |pages=660–78 |year=2010 |pmid=20101749 |doi=10.1002/hep.23294 |url=}}</ref>
Primary sclerosing cholangitis must be differentiated from causes of secondary sclerosing cholangitis. These include:<ref name="pmid27653566">{{cite journal |vauthors=Lazaridis KN, LaRusso NF |title=Primary Sclerosing Cholangitis |journal=N. Engl. J. Med. |volume=375 |issue=12 |pages=1161–70 |year=2016 |pmid=27653566 |doi=10.1056/NEJMra1506330 |url=}}</ref><ref name="pmid20101749">{{cite journal |vauthors=Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ |title=Diagnosis and management of primary sclerosing cholangitis |journal=Hepatology |volume=51 |issue=2 |pages=660–78 |year=2010 |pmid=20101749 |doi=10.1002/hep.23294 |url=}}</ref>
*Abdominal [[trauma]]
*[[AIDS]]-related cholangiopathy
*[[Amyloidosis]]
*Chronic bacterial [[cholangitis]]
*[[GVHD]]
*[[Hepatic]] inflammatory pseudo tumor
*[[Histiocytosis X]]
*[[Iatrogenic]] biliary [[strictures]], due to [[surgery]] or [[ERCP]]
*[[IgG]]4-associated [[cholangitis]]
*[[Infectious]] or [[ischemic]] cholangiopathy
*[[Cholangiocarcinoma]]
*[[Choledocholithiasis]]
*Diffuse intra-hepatic [[metastases]]
*[[Eosinophilic]] [[cholangitis]]
*Intra-arterial [[chemotherapy]]
*[[Mast cell]] cholangiopathy
*[[Portal hypertension|Portal hypertensive]] biliopathy
*Recurrent [[pancreatitis]]
*Recurrent [[pyogenic]] [[cholangitis]]
*[[Sarcoidosis]]


'''Primary sclerosing cholangitis must be differentiated from other causes of jaundice:'''
'''Primary sclerosing cholangitis must be differentiated from other causes of jaundice and pruritis:'''
<small>
<small>
{| align="center"
{| align="center"
Line 59: Line 39:
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary sclerosing cholangitis
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary sclerosing cholangitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/↑
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/↑
Line 73: Line 53:
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 149: Line 129:


'''Primary sclerosing cholangitis must be differentiated from other abdominal pain causes:'''
'''Primary sclerosing cholangitis must be differentiated from other abdominal pain causes:'''
<small>
 
{| align="center"
{| align="center"
|-
|-
Line 588: Line 568:
|}
|}
|}
|}
</small>
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 21:42, 8 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2] Akshun Kalia M.B.B.S.[3]

Overview

Primary sclerosing cholangitis must be differentiated from causes of secondary sclerosing cholangitis.

Differentiating Primary sclerosing cholangitis from other Diseases

Primary sclerosing cholangitis must be differentiated from causes of secondary sclerosing cholangitis. These include:[1][2]

Primary sclerosing cholangitis must be differentiated from other causes of jaundice and pruritis:

Classification of jaundice based on etiology Disease History and clinical manifestations Diagnosis
Lab Findings Other blood tests Other diagnostic
Family history Fever RUQ Pain Pruritis AST ALT ALK BLR Indirect BLR Direct Viral serology
Cholestatic Jaundice Primary sclerosing cholangitis -/+ + + + N/↑ N/↑ N - Beading on MRCP Liver biopsy
Common bile duct stone -/+ -/+ + + N N N - Dilated ducts on sono CT/ERCP
Hepatitis A cholestatic type - -/+ + + N N N + HAV- AB Abdominal ultrasound
EBV / CMV hepatitis - -/+ + + N N N + Positive serology
Primary biliary cirrhosis -/+ - -/+ + N/↑ N/↑ N - AMA positive Liver biopsy
Pancreatic carcinoma + - -/+ - N/↑ N/↑ N - Mass on ultrasond CT scan for diagnosis

Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram


Primary sclerosing cholangitis must be differentiated from other abdominal pain causes:

Disease Clinical manifestations Diagnosis Comments
Symptoms Signs
Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Diarrhea Weight loss Hypo-

tension

Guarding Rebound Tenderness Lab Findings Imaging
Primary sclerosing cholangitis RUQ + + ERCP and MRCP shows
  • Multiple segmental strictures
  • Mural irregularities
  • Biliary dilatation and diverticula
  • Distortion of biliary tree
  • The risk of cholangiocarcinoma in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population.
Acute suppurative cholangitis RUQ + + + + + + +
  • Abnormal LFT
  • WBC >10,000
  • Ultrasound shows biliary dilatation/stents/tumor
  • Septic shock occurs with features of SIRS
Acute cholangitis RUQ + +
  • Ultrasound shows biliary dilatation/stents/tumor
  • Biliary drainage (ERCP) + IV antibiotics
Acute cholecystitis RUQ + + + Ultrasound shows:
  • Gallstone
  • Inflammation
Disease Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Diarrhea Weight loss Hypo-

tension

Guarding Rebound Tenderness Lab Findings Imaging Comments
Acute pancreatitis Epigastric + + ± ±
  • Ultrasound shows evidence of inflammation
  • CT scan shows severity of pancreatitis
  • Pain radiation to back
Chronic pancreatitis Epigastric ± ± + +
  • Increased amylase / lipase
  • Increased stool fat content
  • Pancreatic function test
CT scan
  • Calcification
  • Pseudocyst
  • Dilation of main pancreatic duct
  • Predisposes to pancreatic cancer
Pancreatic carcinoma Epigastric + + + +

Skin manifestations may include:

Primary biliary cirrhosis RUQ/Epigastric +
  • Increased AMA level, abnormal LFTs
  • ERCP
  • Pruritis
Cholelithiasis RUQ/Epigastric ± ± ±
  • Fatty food intolerance
Biliary colic RUQ + +
  • Ultrasound
Disease Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Diarrhea Weight loss Hypo-

tension

Guarding Rebound Tenderness Lab Findings Imaging Comments
Inflammatory bowel disease Diffuse ± ± + +

Extra intestinal findings:

Whipple's disease Diffuse ± ± + + ± Endoscopy is used to confirm diagnosis.

Images used to find complications

Extra intestinal findings:
Viral hepatitis RUQ + + + Positive in Hep A and E + Positive in fulminant hepatitis Positive in acute +
  • Abnormal LFTs
  • Viral serology
  • US
  • Hep A and E have fecal-oral route of transmission
  • Hep B and C transmits via blood transfusion and sexual contact.
Disease Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Diarrhea Weight loss Hypo-

tension

Guarding Rebound Tenderness Lab Findings Imaging Comments
Liver abscess RUQ + + + + ± + + + ±
  • US
  • CT
Hepatocellular carcinoma/Metastasis RUQ + + +
  • US
  • CT
  • Liver biopsy

Other symptoms:

Cirrhosis RUQ + + + US
  • Stigmata of liver disease
  • Cruveilhier- Baumgarten murmur
Spontaneous bacterial peritonitis Diffuse + Positive in cirrhotic patients + ± + +
  • Ascitic fluid PMN>250 cells/mm³
  • Culture: Positive for single organism
  • Ultrasound for evaluation of liver cirrhosis

References

  1. Lazaridis KN, LaRusso NF (2016). "Primary Sclerosing Cholangitis". N. Engl. J. Med. 375 (12): 1161–70. doi:10.1056/NEJMra1506330. PMID 27653566.
  2. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010). "Diagnosis and management of primary sclerosing cholangitis". Hepatology. 51 (2): 660–78. doi:10.1002/hep.23294. PMID 20101749.


Template:WikiDoc Sources